These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8515418)

  • 1. Synthesis and evaluation of the antitumor activity of 4,5-diamino-substituted 1,2-benzoquinones.
    Huang ZD; Chen YN; Menon K; Teicher BA
    J Med Chem; 1993 Jun; 36(13):1797-801. PubMed ID: 8515418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
    Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
    Khan AH; Driscoll JS
    J Med Chem; 1976 Feb; 19(2):313-7. PubMed ID: 1249812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.
    Giorgi-Renault S; Renault J; Gebel-Servolles P; Baron M; Paoletti C; Cros S; Bissery MC; Lavelle F; Atassi G
    J Med Chem; 1991 Jan; 34(1):38-46. PubMed ID: 1992140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
    Egorin MJ; Fox BM; Spiegel JF; Gutierrez PL; Friedman RD; Bachur NR
    Cancer Res; 1985 Mar; 45(3):992-9. PubMed ID: 3971389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1,12-diaziridinyl-4,9-diazadodecane.
    Li Y; Eiseman JL; Sentz DL; Rogers FA; Pan SS; Hu LT; Egorin MJ; Callery PS
    J Med Chem; 1996 Jan; 39(1):339-41. PubMed ID: 8568824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones.
    Lea JS; Garner HJ; Butler J; Hoey BM; Ward TH
    Biochem Pharmacol; 1988 May; 37(10):2023-5. PubMed ID: 2837220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytotoxic activity of 2-dialkylaminoethylamino substituted xanthenone and thioxanthenone derivatives.
    Kostakis I; Ghirtis K; Pouli N; Marakos P; Skaltsounis AL; Leonce S; Caignard DH; Atassi G
    Farmaco; 2000; 55(6-7):455-60. PubMed ID: 11204746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
    Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
    J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel diaziridinylquinone-acridine conjugates.
    Di Francesco AM; Mayalarp SP; Kim S; Butler J; Lee M
    Anticancer Drugs; 2003 Sep; 14(8):601-15. PubMed ID: 14501382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytotoxicity of diaziquone toward Chinese hamster ovary cells under hypoxic and aerobic exposure conditions.
    O'Brien PJ; Kaul HK; Rauth AM
    Cancer Res; 1990 Mar; 50(5):1516-20. PubMed ID: 2302714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
    Winski SL; Hargreaves RH; Butler J; Ross D
    Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones.
    Bailey SM; Suggett N; Walton MI; Workman P
    Int J Radiat Oncol Biol Phys; 1992; 22(4):649-53. PubMed ID: 1544832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photosensitization of leukemia L1210 cells with diaziquone.
    Kessel D; Thompson P
    Cancer Res; 1986 Nov; 46(11):5587-8. PubMed ID: 3756904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro cytotoxic evaluation of N-substituted benzo[5,6]cycloheptal[b]indoles.
    Joseph B; Alagille D; Mérour JY; Léonce S
    Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):1872-6. PubMed ID: 11145134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of 10-propargyl-10-deazaaminopterin.
    DeGraw JI; Colwell WT; Piper JR; Sirotnak FM
    J Med Chem; 1993 Jul; 36(15):2228-31. PubMed ID: 8340923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photosensitization of MCF-7 cells with diaziquone using visible light: correlation with DNA strand breaks and free radical production.
    al-Nabulsi I; Gutierrez PL
    Photochem Photobiol; 1992 Aug; 56(2):201-9. PubMed ID: 1502264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone.
    Ngo EO; Nutter LM; Sura T; Gutierrez PL
    Chem Res Toxicol; 1998 Apr; 11(4):360-8. PubMed ID: 9548807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo].
    Numasaki Y; Takahashi K; Masuda E; Nohara C; Maeda H
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2289-94. PubMed ID: 1834021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.